-
March 10, 2009
Production of 99Mo for Nuclear Medicine by 100Mo(n,2n)99Mo
We have proposed a new route to produce 99Mo for nuclear medicine by the 100Mo(n,2n)99Mo reaction. The reaction cross section is known to be ∼1.5 b in the neutron energy, En, range…
Read More -
February 25, 2009
B&W taps DOE official to head isotope program
Babcock & Wilcox has picked Daniel E. Glenn, a Department of Energy official, to lead research and development for its medical-isotope initiative, which might lead to the establishment…
Read More -
February 12, 2009
NRG brings the High Flux Reactor back into operation
Today, the Dutch Council of Ministers have given permission to allow the restart of the High Flux Reactor in Petten with additional safety related measures in place…
Read More -
February 4, 2009
Urgent Update On The European Situation
The production of Tc-99m for medical imaging (daughter isotope of the Mo-99 produced by irradiation of the U-235 targets in research reactors)…
Read More -
January 26, 2009
B&W strikes isotopes deal with health care firm
Babcock & Wilcox is entering a venture with a health care products company to produce an important medical isotope that currently is not made in the U.S…
Read More -
January 23, 2009
NRG requests permission to restart the High Flux Reactor, Petten
This week NRG has requested permission from the relevant authorities to restart the High Flux Rector in Petten. Following a large maintenance and inspection program in August 2008…
Read More
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.